General Information of the Compound
| Compound ID |
CP0102467
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(oxazolo[4,5-b]pyridin-2-yl)-6-phenylhexan-1-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(oxazolo[4,5-b]pyridin-2-yl)-6-phenylhexan-1-one
1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one
288862-83-9
ACM288862839
BDBM50161518
CHEMBL175854
CTK8E9849
DTXSID10435440
HMS3649E22
J-017316
LEI-104
MolPort-009-018-760
PHOP
RT-015038
SCHEMBL3964367
SR-01000946606
SR-01000946606-1
ZINC13611906
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H18N2O2
|
||||||||||||||||||
| Molecular Weight |
294.354
|
||||||||||||||||||
| Canonical SMILES |
O=C(CCCCCc1ccccc1)c1nc2ncccc2o1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H18N2O2/c21-15(18-20-17-16(22-18)12-7-13-19-17)11-6-2-5-10-14-8-3-1-4-9-14/h1,3-4,7-9,12-13H,2,5-6,10-11H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
VPZHQLPAKFVGKX-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( 1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one )
| Drug Name | 1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one | ||
|---|---|---|---|